Investors in Reckitt Benckiser Group plc Should Contact Levi & Korsinsky Before August 4, 2025 to Discuss Your Rights

Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser's cow's milk-based formula, Enfamil, posed an increased risk of NEC (necrotizing enterocolitis) in preterm infants, which was not disclosed [2]. - It is alleged that the company made false statements regarding its business operations and sales prospects, which were materially misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].